22nd International Symposium on Infections in the Critically Ill Patient

Infection and Sepsis Symposium 2017

KEYNOTE SPEAKERS

Prof. Antonio Artigas, MD, PhD

Prof. Antonio Artigas, MD, PhD

ICU Management & Practice Editorial Board Member

******@***cspt.es

Dept. of Intensive Care Medicine Hospital de Sabadell - CIBER de Enfermedades Respiratorias Corporació Sanitaria I Universitària Parc Taulí Sabadell, Spain
Prof. Michael Niederman, MD, MACP, FCCP, FCCM, FERS

Prof. Michael Niederman, MD, MACP, FCCP, FCCM, FERS

******@***med.cornell.edu

Clinical Director, Pulmonary and Critical Care - New York Presbyterian-Weill Cornell Medical Center (2015-)
Professor of Clinical Medicine - Weill Cornell Medical College (2015-)
Prof Antoni Torres

Prof Antoni Torres

******@***clinic.ub.es

Hospital Clinic
Prof Jean-Louis Vincent, MD, PhD

Prof Jean-Louis Vincent, MD, PhD

Editor-in-Chief, ICU Management & Practice

******@***icu-management.org

Professor - Department of Intensive Care Erasme Hospital Université libre de Bruxelles
Brussels, Belgium

Exhibit

Symposia

Workshops

Organiser

Sponsor



The aim of this two days symposium is to review current concepts, technology and present advances in infections in the critically ill patients. Sepsis, Pulmonary Infections, Basic Research, Pulmonary Infections Treatment and ProphylaxisTherapyofsevereinfections will bethetopicsof the main sessions presented by experts who will review and update the new advances on infections in the critically ill patient. At the end of each session a Clinical Controversy, Pannel Discussion or Case Report Discussion will be organized.

Posters


The posters should be sent before 18th December 2016 to this address: [email protected]

ORGANIZED BY

Antonio Artigas, MD
Critical Care Center, Sabadell Hospital, University Institute Parc Taulí, Autonomous
University of Barcelona, Ciberes, Spain

Jean Carlet, MD
Direction de l’Amélioration de la Qualité et de la Securité des Soins, Paris, France

Paulo Mergulhão, MD
Emergency and Intensive Care Medicine Department Centro Hospitalar Sao Joao Faculty of Medicine, University of Porto, Porto, Portugal

Michael Niederman, MD
Division of Pulmonary and Critical Care Medicine, New York Presbyterian Hospital, Weill Cornell Medical College, USA

José Arthur Paiva, MD
Emergency and Intensive Care Medicine Department Centro Hospitalar Sao Joao, Faculty of Medicine, University of Porto, Porto, Portugal

Antoni Torres, MD
Pulmonology Department, Clinic Hospital of Barcelona, Ciberes, Spain,



ENDORSED BY





Prior to 31/12/2016

After 31/12/2016

*MEMBERS

250€

350€

NON MEMBERS

350€

450€

One day offer

Prior to 31/12/2016

After 31/12/2016

*MEMBERS

85€

150€

NON MEMBERS

100€

180€


The following registration fees include access to the Scientific Sessions and the Commercial Exhibition, Conference documents, Certificate of Attendance and Coffee Breaks

* Members of:

- Ciberes

- ESA

- GSA

- ICHS

- ISF

- Separ

- SPDIMC

- SPD

- SRLF

** A letter signed by the institution responsible is required to get this fee..


To Register, Please fill the form (type or block capital letters) and mail it or fax it directly to the Symposium Technical Secretariat:


Diagonal 662-664.
08034 Barcelona, Spain
Tel. + 34 93 252 04 00
Fax +34 93 206 57 91
[email protected]


PDF Registration Form


Wednesday, February 8th, 2017


08:45

Introduction

A.Artigas, MD (Sabadell, Spain)

J.Carlet, MD (Paris, France)

P.Mergulhão, MD (Porto, Portugal)

M.Niederman, MD (New York, USA)

JA.Paiva, MD (Porto, Portugal)


I. SEPSIS

09:00

Surviving Sepsis Campaign Guidelines 2016: What changed? -M.Levy, MD (Rhode Island, USA)

09:20

Outlook for Sepsis: Do We Have a Roadmap- T.Calandra, MD (Lausanne, Switzerland)

09:40

Post-ICU Sepsis: The OUTCOME Study- J.Gonçalves Pereira, MD (Lisboa, Portugal)

10:00

Big Data For Better Sepsis Management -H.Gerlach, MD (Berlin, Germany)

10:20

Discussion

10:30

Break (Exhibition Area). Poster Discussion


II. THE END OF EGDT?

11:00

Lactate Clearance: How Much Is a Marker Response?- M.Levy, MD (Rhode Island, USA)

11:20

Protocol vs Individualized Treatment- M.Cecconi, MD (London, UK)

11:40

What Do I in my ICU? -C.Martin, MD (Marseille, France)

12:00

Therapeutical Goals For 2017 and Beyond- JL.Vincent, MD (Brussels, Belgium)

12:20

Discussion

12:30

Debate: New Sepsis Definitions: Real Progress?

Moderator: I.Martin Loeches, MD (Dublin, Ireland)

Pro: JL.Vincent, MD (Brussels, Belgium)

Con: R.Ferrer, MD (Barcelona, España)

13:00

Lunch


Symposium

VASCULAR TONE OR VOLUME STATUS?

Moderators: JL.Teboul, MD (Paris, France)

C.Martin, MD (Marseille, France)


14:00

Volume Status and Fluid Resuscitation: What is the solution? -M.Cecconi, MD (London, UK)

14:20

The SOSD Phases of Fluid Therapy- D.De Backer, MD (Brussels, Belgium)

14:40

Vassopressors in Sepsis: When to Start?- JL.Teboul, MD (Paris, France)

15:00

Discussion


III. DYSFUNCTION OF MICROCIRCULATION IN SEPSIS

15:30

Role Od Gut in Sepsis and MOF?- J. De Waele, MD (Gent, Belgium)

15:50

How to evaluate the Microcirculation?- C.Ince, MD (Amsterdam, The Netherlands)

16:10

How to Improve Microcirculation?- D.De Backer, MD (Brussels, Belgium)

16:30

Discussion

16:40

Break (Exhibition Area). Poster Discussion

Symposium

SEPSIS ASSOCIATED COAGULOPATHY

Moderators: A. Artigas, MD (Sabadell, Spain)

M.Schultz, MD (Amsterdam, The Netherlands)


17:10

Sepsis-Associated Coagulopathy: Still Common and

Still Important- A. Artigas, MD (Sabadell, Spain)

17:30

Organ Dysfunction and Coagulation in Sepsis- M.Levi, MD (Amsterdam, The Netherlands)

17:50

Thrombomodulin In Sepsis: The SCARLET Study- JL.Vincent, MD (Brussels, Belgium)

18:10

Discussion


Thursday, February 9th, 2017


IV. NEW INSIGHTS IN THE PATHOGENESIS OF PNEUMONIA IN INTUBATED AND MECHANICAL VENTILATED PATIENTS

09:00

Changes in Microbiome During Mechanical Ventilation- LD Boss, MD (Amsterdam, Netherlands)

09:20

From Tracheobronchitis to VAP- S. Nseir, MD (Lille, France)

09:40

Selective Advantage of Multi-Drug Resistant Microbe During Prolonged Ventilation- I.Martin Loeches, MD (Dublin, Ireland)

10:00

Discussion

10:10

Break (Exhibition Area). Poster Discussion


V. MANAGEMENT OF PULMONARY INFECTIONS

10:40

Management of Severe Influenza Infections- MS.Niederman, MD (New York, USA)

11:00

Virus as a Cause of VAP- F.Froes, MD (Lisboa, Portugal)

11:20

Tracheostomy Practices: Are Risk Factors for VAP?- M.Antonelli, MD (Rome, Italy)

11:40

Ventilatory Support and VAP Prevention in Auster Seetings, Also Applicable in Your Unit? -M.Schultz, MD (Amsterdam, The Netherlands)

12:00

Novel Approaches to Treat Pulmonary Infections- T.Welte, MD (Hannover, Germany)

12:20

Discussion

12:20

Lunch


Symposium

CONTROVERSIES AND ADVANCES IN THE MANAGEMENT OF VAP

Moderators: I.Martin Loeches, MD (Dublin, Ireland)

JM Pereira, MD (Porto, Portugal)


13:30

Can Antiinflammatory Therapy Help Improve Outcome in VAP?- A.Torres, MD (Barcelona, Spain)

13:50

Are New Antibiotics Going To Help Us Manage VAP in the ICU?- MS.Niederman, MD (New York, USA)

14:10

Can Biomarkers Help With Antibiotic Stewardship?- J.Chastre, MD (Paris, France)

14:30

Discussion


VI. POINT-OF-CARE APPROACH TO INFECTIONS IN THE ICU

14:40

Early MIcrobiological Diagnostics on the ICU. Is it Possible?- E.Bouza, MD (Madrid, Spain)

15:00

Virus Diagnosis Is Important in the ICU?- J.Chastre, MD (Paris, France)

15:20

Biomarkers In AKI

15:40

Sepsis Biomarkers: An Overview- JL.Vincent, MD (Brussels, Belgium)

16:00

Discussion

16:10

Break (Exhibition area). Poster Discussion


VII. FROM THE PHYSIOPATHOLOGY TO THE BEDSIDE: THE IMMUNE RESPONSE

16:40

Sepsis: Ressistance vs Tolerance. Change of Paradigm- L.Moita, MD (Lisboa, Portugal)

17:00

Immunosupression in Sepsis: Is it important?- D.Payen, MD (Paris, France)

17:20

Semi-Selective Immune Modulation Using Hemoabsorption

17:40

Polimixin B Hemoperfusion: The EUPHRATES Study- M.Antonelli, MD (Rome, Italy)

18:00

Discussion


Friday, February 10th, 2017


VIII. NEW INSIGHTS OF ANTIBIOTIC THERAPY

09:00

New Antibiotics for the Treatment of Severe Infections -T.Calandra, MD (Lausanne, Switzerland)

09:20

Can We Reduce Antibiotic Resistance?- J.Carlet, MD (Paris, France)

09:40

Combination of Betalactam: When and Why?- JM Pereira, MD (Porto, Portugal)

10:00

Antibiotic in Extracorporeal Techniques -J.Gonçalves Pereira, MD (Lisboa, Portugal)

10:20

Continuous or Prolonged Infussion of Antibiotics- J.De Waele, MD (Gent, Belgium)

10:50

Discussion

11:00

Break (Exhibition Area). Poster Discussion


IX. WHAT IS NEW IN FUNGAL INFECTIONS

11:30

Prophylaxis and Prevention Therapy for Fungal Infections- T.Calandra, MD (Lausanne, Switzerland)

11:50

D-Escalation Therapy in Patients With Invasive Candidiasis- J.Garnacho-Montero, MD (Sevilla, Spain)

12:10

How Could We Reduce Antifungal Use? The STAFE Study-S.Nseir, MD (Lille, France)

12:30

Fungemia: What Is New? -JA.Paiva, MD (Porto, Portugal)

12:50

Discussion

13:00

Closing Remarks

Postgraduate Courses


NUTRITION THERAPY: State of the Art

ANTIBIOTIC THERAPY




More events

ISTH 2022 Congress

Sat, 9 Jul 2022 - Wed, 13 Jul 2022


Royal Victoria Dock
London, E16 1XL
United Kingdom
Workshop Regional Anaesthesia 2022

Thu, 25 Aug 2022 - Fri, 26 Aug 2022


Hohenzollernring 70
Münster, 48145
Germany
ERS International Congress 2022

Sun, 4 Sep 2022 - Tue, 6 Sep 2022


Barcelona, 08038
Spain
ICCA STROKE 2022

Fri, 9 Sep 2022 - Sat, 10 Sep 2022

77th Annual Meeting of The ASSH 2022

Thu, 29 Sep 2022 - Sat, 1 Oct 2022

ResusNL 2022 – Breathe

Thu, 6 Oct 2022 - Fri, 7 Oct 2022


Otto Reuchlinweg 996 3072 MD
Rotterdam
Netherlands
EUSEM 2022-European Congress of Emergency Medicine

Sat, 15 Oct 2022 - Wed, 19 Oct 2022


Messedamm 22
Berlin, 14055
Germany

Related articles